To include your compound in the COVID-19 Resource Center, submit it here.

Crinone regulatory update

FDA accepted for review an NDA from Columbia for Prochieve vaginal progesterone gel to reduce the risk of preterm

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE